Public Awareness and Understanding of PC in the UAE

March 5, 2025 updated by: Humaid O. Al-Shamsi, Burjeel Cancer Institute

Public Awareness and Understanding of Palliative Care in the United Arab Emirates: Insights from a Population-Based Cross-Sectional Study

Palliative care (PC) is essential medical care for improving the quality of life for patients with life-threatening illnesses and their families. There has been substantial evolution of PC services in the United Arab Emirates (UAE), yet public awareness regarding PC remains shallow, hindering its utilization and acceptance on a large scale.

Study Overview

Status

Completed

Conditions

Detailed Description

This study aimed to evaluate public perceptions and awareness of PC in the UAE. A cross-sectional survey was conducted in both Arabic and English. This study emphasizes the need of addressing these gaps to integrate PC effectively into the UAE healthcare system, ensuring equitable access and improved quality of life for patients and their families.

Study Type

Observational

Enrollment (Actual)

824

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The target population included residents of the UAE, both Emiratis and expatriates, who could read and respond in either English or Arabic.

Description

Inclusion Criteria:

  • UAE residents
  • Provided informed consent to participate
  • Completed the survey in either Arabic or English

Exclusion Criteria:

  • Non-UAE residents
  • Incomplete survey responses (if applicable)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Familiarity and Understanding of Palliative and Supportive Care as Measured by a Structured Survey
Time Frame: Surveys were conducted in Arabic from July 25, 2024, to August 18, 2024, and in English from August 5, 2024, to August 18, 2024.

The study assessed participants' awareness, familiarity, and understanding of palliative and supportive care through a structured questionnaire. The survey includes Likert-scale and multiple-choice questions designed to evaluate:

  • Self-reported familiarity with palliative and supportive care concepts
  • Knowledge of available palliative care services
  • Perceived importance of palliative care in the healthcare system
  • Disparities in responses between Arabic-speaking and English-speaking groups.

Responses were analyzed quantitatively by calculating the proportion of participants at different familiarity levels i.e., Very familiar, somewhat familiar, Neutral/not sure, not very familiar, not familiar at all and comparing trends across language groups. Percentages were calculated and categorical responses were summarized using frequency distributions.

Surveys were conducted in Arabic from July 25, 2024, to August 18, 2024, and in English from August 5, 2024, to August 18, 2024.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 25, 2024

Primary Completion (Actual)

August 18, 2024

Study Completion (Actual)

January 15, 2025

Study Registration Dates

First Submitted

February 3, 2025

First Submitted That Met QC Criteria

March 5, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 5, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • BH/REC/073/24

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The individual participant data (IPD) from this study will not be publicly disclosed due to confidentiality concerns. However, aggregated data supporting the findings of this study may be available from the corresponding author upon reasonable request, subject to institutional and ethical approvals.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe